Overview
Prednicarbate is a relatively new topical corticosteroid drug that displays a similar potency as hydrocortisone. It is used in the treatment of inflammatory skin diseases, such as atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. The anti-inflammation action of corticosteroids is associated with the inhibition of the interleukin 1-alpha cytokine within keratinocytes. IL-1a is also found in fibroblasts, where it is responsible for proliferation, collagenase induction and IL-6 synthesis, which are related to skin thickness.
Indication
常用于各种炎性皮肤病的局部治疗。
Associated Conditions
- Dermatosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/01/16 | Phase 1 | Completed | |||
2005/09/08 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Fougera Pharmaceuticals Inc. | 0168-0410 | TOPICAL | 1.0 mg in 1 g | 12/31/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| DERMATOP EMOLLIENT CREAM | bausch health, canada inc. | 02230642 | Cream - Topical | 0.1 % / W/W | 3/21/2001 |
| DERMATOP OINTMENT | bausch health, canada inc. | 02227517 | Ointment - Topical | 0.1 % / W/W | 3/21/2001 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| BATMEN 2,5 MG/G POMADA | A. Menarini Latin America S.L. | 60456 | POMADA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| PEITEL 2,5 MG/G SOLUCION CUTANEA | Galenicum Derma S.L. | 60393 | SOLUCIÓN CUTÁNEA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| BATMEN 2,5 MG/G UNGÜENTO | A. Menarini Latin America S.L. | 60457 | POMADA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| PEITEL 2,5 MG/G POMADA | Galenicum Derma S.L. | 60370 | POMADA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| BATMEN SOLUCION | Laboratorios Menarini S.A. | 60459 | SOLUCIÓN CUTÁNEA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
| BATMEN 2,5 MG/G CREMA | A. Menarini Latin America S.L. | 60458 | CREMA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| PEITEL 2,5 MG/G CREMA | Galenicum Derma S.L. | 60372 | CREMA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| PEITEL 2,5 MG/G UNGUENTO | 60371 | POMADA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.